Likewise, the demonstration by these investigators that GVHD-promoting effects were independent of TLR2 and TLR7 support our conclusion that IL-33 is a critical T cell–stimulating DAMP after alloHCT. The gene discussed is IL33; the disease is graft versus host disease.